These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17502657)

  • 1. Severe intimal hyperplasia after sirolimus eluting stent deployment: evaluation by optical coherence tomography.
    Gupta R; Raffel OC; Jang IK
    Heart; 2007 Jun; 93(6):754. PubMed ID: 17502657
    [No Abstract]   [Full Text] [Related]  

  • 2. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neointimal proliferation around malapposed struts of a sirolimus-eluting stent: optical coherence tomography findings.
    Takano M; Jang IK; Mizuno K
    Eur Heart J; 2006 Aug; 27(15):1763. PubMed ID: 16476695
    [No Abstract]   [Full Text] [Related]  

  • 5. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of organized thrombus to in-stent restenosis after sirolimus-eluting stent implantation: optical coherence tomography findings.
    Fujii K; Masutani M; Ohyanagi M
    Eur Heart J; 2008 Jun; 29(11):1385. PubMed ID: 18077442
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist?
    Takano M; Yamamoto M; Inami S; Murakami D; Seimiya K; Ohba T; Seino Y; Mizuno K
    J Am Coll Cardiol; 2008 Mar; 51(9):968-9. PubMed ID: 18308167
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various optical coherence tomographic findings in restenotic lesions after sirolimus-eluting stent implantation.
    Takano M; Xie Y; Murakami D; Inami S; Yamamoto M; Ohba T; Seino Y; Mizuno K
    Int J Cardiol; 2009 May; 134(2):263-5. PubMed ID: 18403032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel neointimal formation over sirolimus-eluting stents identified by coronary angioscopy and optical coherence tomography.
    Murakami D; Takano M; Yamamoto M; Inami S; Ohba T; Seino Y; Mizuno K
    J Cardiol; 2009 Apr; 53(2):311-3. PubMed ID: 19304139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion.
    Takebayashi H; Kobayashi Y; Dangas G; Fujii K; Mintz GS; Stone GW; Moses JW; Leon MB
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):496-9. PubMed ID: 14624428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
    Liuzzo JP; Ambrose JA; Coppola JT
    J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vessel response evaluation by optical coherence tomography after drug-eluting stent implantation in the left main coronary artery].
    Giuliani G; Maehara A; Parodi G
    G Ital Cardiol (Rome); 2010 Mar; 11(3):246. PubMed ID: 20550066
    [No Abstract]   [Full Text] [Related]  

  • 17. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography.
    Matsumoto D; Shite J; Shinke T; Otake H; Tanino Y; Ogasawara D; Sawada T; Paredes OL; Hirata K; Yokoyama M
    Eur Heart J; 2007 Apr; 28(8):961-7. PubMed ID: 17135281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement.
    Neumann FJ; Desmet W; Grube E; Brachmann J; Presbitero P; Rubartelli P; Mügge A; Di Pede F; Füllgraf D; Aengevaeren W; Spedicato L; Popma JJ
    Circulation; 2005 Apr; 111(16):2107-11. PubMed ID: 15851617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
    Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.